YDKG Q4 2012 Earnings EPS Falls Short of Estimates as Stock Gains 322 Textron Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Gain Scinai Immunotherapeutics SCNI Q4 2023 Earnings NarrowerThanExpected Loss Amid Operational Adjustments SLN Q4 2024 Earnings Positive EPS Amid Continued Clinical Progress FAF Q1 2026 Earnings EPS Beat by 256 Despite Mixed Market Reaction PATK Q1 2026 Earnings EPS Beats Estimates Stock Rises 16